Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Sentinel lymph node biopsy is the most accurate technique for establishing melanoma patient prognosis but is associated with morbidity and is of little value in those tumors that first metastasize to sites other than the regional nodal basin. Noninvasive methods of establishing prognosis are therefore desirable. We have used the novel technology of tissue microarray to study a cohort of 120 patients with melanoma with long-term follow-up data for the expression of P-cadherin. The tissue microarray was successfully constructed and stained. Loss of P-cadherin expression was found to be significantly correlated with outcome (log rank chi2 = 10.1336, P = 0.0015). The results suggest a fundamental role for P-cadherin in melanoma progression and identify it as a potential prognostic marker and a possible target for therapeutic manipulation.

Type

Journal article

Journal

Ann Plast Surg

Publication Date

09/2005

Volume

55

Pages

316 - 320

Keywords

Adult, Aged, Aged, 80 and over, Cadherins, Cohort Studies, Female, Follow-Up Studies, Humans, Male, Melanoma, Microarray Analysis, Middle Aged, Neoplasm Staging, Prognosis, Sentinel Lymph Node Biopsy, Skin Neoplasms